For more information or to see if you may be eligible, please contact the site closest to you.
If you have questions about the study—or don't live near any of the sites—contact us at 1-888-770-6366.
For study information outside the United States and Canada View study locations near you
The ICARA study is evaluating the safety and effectiveness of an investigational drug, bapineuzumab, aimed at slowing down the disease progression.